Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373685
Status:
COMPLETED
Last Update Posted:
2021-03-03
First Post:
2006-09-07
Brief Title:
GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs NSAIDS
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteoarthritis |
Keywords:
| Name | View |
|---|---|
| GI events in patients with moderate GI risk treated with NSAIDS | View |